• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磺脲类药物治疗的糖尿病患者的慢性微血管并发症:与血糖控制、危险因素及病程的相关性

Chronic Microvascular Complications in Sulfonylureas-Treated Diabetic Patients: Correlations with Glycemic Control, Risk Factors and Duration of the Disease.

作者信息

Confederat Luminita-Georgeta, Stefan Roxana, Condurache Mihaela-Iustina, Dragostin Oana-Maria

机构信息

Department of Biomedical Sciences, "Grigore T. Popa" University of Medicine and Pharmacy of Iasi, 700115 Iași, Romania.

"Providența" Medical Center, 10 Ștefan Cel Mare Avenue, 700259 Iași, Romania.

出版信息

Clin Pract. 2024 Dec 30;15(1):7. doi: 10.3390/clinpract15010007.

DOI:10.3390/clinpract15010007
PMID:39851790
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11764216/
Abstract

: Diabetes has become one of the most challenging public health problems due to the alarming increase in prevalence and the morbidity and mortality attributed to its acute and chronic complications. This study aimed to investigate the development of chronic microvascular complications in sulfonylureas-treated diabetic patients and their correlations with glycemic control, risk factors and duration of the disease. : This study included 200 patients that presented to "Providența" Medical Center, Iași. The information was obtained in a retrospective manner based on the observation sheets of the patients. A database was created, analyzed and statistically processed using the (Version 15) and the . : The prevalence of diabetic polyneuropathy was 33.5%, while diabetic retinopathy was found in 27% of cases. For diabetic polyneuropathy, the results of the statistical analysis demonstrated a statistically significant dependence of the risk factors hyperlipidemia (significance level = 0.01) and overweight/obesity (significance level = 0.05). For diabetic retinopathy, the results demonstrated a statistically significant dependence of the risk factors hypertension (significance level = 0.05) and hyperlipidemia (significance level = 0.01). : The present study reveals a strong correlation between the presence of risk factors and the development of microvascular complications of diabetes.

摘要

由于糖尿病患病率惊人地上升以及其急慢性并发症所致的发病率和死亡率,糖尿病已成为最具挑战性的公共卫生问题之一。本研究旨在调查磺脲类药物治疗的糖尿病患者慢性微血管并发症的发生情况及其与血糖控制、危险因素和病程的相关性。:本研究纳入了200名到雅西“Providența”医疗中心就诊的患者。信息是基于患者的观察表以回顾性方式获取的。使用(版本15)和创建、分析并对一个数据库进行了统计处理。:糖尿病性多发性神经病变的患病率为33.5%,而糖尿病视网膜病变在27%的病例中被发现。对于糖尿病性多发性神经病变,统计分析结果显示危险因素高脂血症(显著性水平 = 0.01)和超重/肥胖(显著性水平 = 0.05)具有统计学上的显著相关性。对于糖尿病视网膜病变,结果显示危险因素高血压(显著性水平 = 0.05)和高脂血症(显著性水平 = 0.01)具有统计学上的显著相关性。:本研究揭示了危险因素的存在与糖尿病微血管并发症的发生之间存在密切关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d35/11764216/1be6c78c8dc5/clinpract-15-00007-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d35/11764216/189bab0e3be9/clinpract-15-00007-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d35/11764216/ba7510a8978b/clinpract-15-00007-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d35/11764216/776a184abd33/clinpract-15-00007-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d35/11764216/1be6c78c8dc5/clinpract-15-00007-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d35/11764216/189bab0e3be9/clinpract-15-00007-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d35/11764216/ba7510a8978b/clinpract-15-00007-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d35/11764216/776a184abd33/clinpract-15-00007-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d35/11764216/1be6c78c8dc5/clinpract-15-00007-g004.jpg

相似文献

1
Chronic Microvascular Complications in Sulfonylureas-Treated Diabetic Patients: Correlations with Glycemic Control, Risk Factors and Duration of the Disease.磺脲类药物治疗的糖尿病患者的慢性微血管并发症:与血糖控制、危险因素及病程的相关性
Clin Pract. 2024 Dec 30;15(1):7. doi: 10.3390/clinpract15010007.
2
Prevalence of microvascular complications and associated factors among diabetes mellitus patients in Ethiopia: Systematic review and meta-analysis.埃塞俄比亚糖尿病患者微血管并发症的患病率及相关因素:系统评价与荟萃分析。
Microvasc Res. 2025 Mar;158:104779. doi: 10.1016/j.mvr.2024.104779. Epub 2024 Dec 26.
3
Prevalence of Metabolic Syndrome and Its Risk Factors Influence on Microvascular Complications in Patients With Type 1 and Type 2 Diabetes Mellitus.1型和2型糖尿病患者代谢综合征的患病率及其危险因素对微血管并发症的影响
Cureus. 2024 Mar 4;16(3):e55478. doi: 10.7759/cureus.55478. eCollection 2024 Mar.
4
A Study of the Mean Platelet Volume and Plasma Fibrinogen in Type Two Diabetes Mellitus Patients Versus Healthy Controls and Their Role as Early Markers of Diabetic Microvascular Complications.2型糖尿病患者与健康对照者的平均血小板体积和血浆纤维蛋白原研究及其作为糖尿病微血管并发症早期标志物的作用
Cureus. 2024 Jul 26;16(7):e65458. doi: 10.7759/cureus.65458. eCollection 2024 Jul.
5
Diabetic microvascular complications and associated factors in patients with type 2 diabetes in Southern Ethiopia.埃塞俄比亚南部 2 型糖尿病患者的糖尿病微血管并发症及其相关因素。
Front Endocrinol (Lausanne). 2024 Jul 4;15:1342680. doi: 10.3389/fendo.2024.1342680. eCollection 2024.
6
The Association of Obesity and Microvascular Complications with Glycemic Control in Patients with Type 2 Diabetes Mellitus.肥胖与微血管并发症与 2 型糖尿病患者血糖控制的关系。
Med Arch. 2020 Feb;74(1):14-18. doi: 10.5455/medarh.2020.74.14-18.
7
Metabolic Syndrome in Type 2 Diabetes Mellitus Patients: Prevalence, Risk Factors, and Associated Microvascular Complications.2型糖尿病患者的代谢综合征:患病率、危险因素及相关微血管并发症
Cureus. 2023 May 16;15(5):e39076. doi: 10.7759/cureus.39076. eCollection 2023 May.
8
Correlation Between Extracutaneous Microvascular Complications and Diabetic Foot Ulcers in Patients with Type 2 Diabetes Mellitus.2 型糖尿病患者皮肤外微血管并发症与糖尿病足溃疡的相关性。
Med Arch. 2020 Dec;74(6):444-449. doi: 10.5455/medarh.2020.74.443-448.
9
Evaluation of Risk Factors for Diabetic Peripheral Neuropathy Among Saudi Type 2 Diabetic Patients with Longer Duration of Diabetes.沙特2型糖尿病病程较长患者糖尿病周围神经病变危险因素的评估
Diabetes Metab Syndr Obes. 2022 Sep 28;15:3007-3014. doi: 10.2147/DMSO.S364933. eCollection 2022.
10
Diabetic Microvascular Complications Among Children and Adolescents in Northwestern Tanzania: A Cross-Sectional Study.坦桑尼亚西北部儿童和青少年的糖尿病微血管并发症:一项横断面研究。
Ann Glob Health. 2020 Apr 24;86(1):43. doi: 10.5334/aogh.2669.

本文引用的文献

1
Management of diabesity: Current concepts.糖尿病肥胖症的管理:当前概念
World J Diabetes. 2023 Apr 15;14(4):396-411. doi: 10.4239/wjd.v14.i4.396.
2
Healthy lifestyle behaviors, mediating biomarkers, and risk of microvascular complications among individuals with type 2 diabetes: A cohort study.健康生活方式行为、中介生物标志物与 2 型糖尿病患者微血管并发症风险的关系:一项队列研究。
PLoS Med. 2023 Jan 10;20(1):e1004135. doi: 10.1371/journal.pmed.1004135. eCollection 2023 Jan.
3
Glycemia Reduction in Type 2 Diabetes - Microvascular and Cardiovascular Outcomes.
2 型糖尿病患者的血糖降低——微血管和心血管结局。
N Engl J Med. 2022 Sep 22;387(12):1075-1088. doi: 10.1056/NEJMoa2200436.
4
Metabolic syndrome and peripheral neuropathy.代谢综合征与周围神经病变。
Muscle Nerve. 2021 Mar;63(3):285-293. doi: 10.1002/mus.27086. Epub 2020 Oct 24.
5
Changes to cardiovascular risk factors over 7 years: a prospective cohort study of in situ urbanised residents in the Chaoyang District of Beijing.7 年内心血管危险因素的变化:北京市朝阳区原地城市化居民的前瞻性队列研究。
BMJ Open. 2020 Mar 16;10(3):e033548. doi: 10.1136/bmjopen-2019-033548.
6
Alcohol consumption, depressive symptoms, and the incidence of diabetes-related complications.饮酒、抑郁症状与糖尿病相关并发症的发生。
J Diabetes. 2019 Jan;11(1):14-22. doi: 10.1111/1753-0407.12822. Epub 2018 Aug 6.
7
IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040.国际糖尿病联盟糖尿病地图:2015年和2040年全球糖尿病患病率估计
Diabetes Res Clin Pract. 2017 Jun;128:40-50. doi: 10.1016/j.diabres.2017.03.024. Epub 2017 Mar 31.
8
Epidemiology of diabetes.糖尿病流行病学
Medicine (Abingdon). 2014 Dec;42(12):698-702. doi: 10.1016/j.mpmed.2014.09.007.
9
Global estimates of diabetes prevalence for 2013 and projections for 2035.全球 2013 年糖尿病患病率估计值及 2035 年预测值。
Diabetes Res Clin Pract. 2014 Feb;103(2):137-49. doi: 10.1016/j.diabres.2013.11.002. Epub 2013 Dec 1.
10
How to prevent and treat pharmacological hypoglycemias.如何预防和治疗药物性低血糖症。
Rev Clin Esp (Barc). 2014 May;214(4):202-8. doi: 10.1016/j.rce.2013.12.011. Epub 2014 Jan 24.